Our Team
Matt is a life sciences strategy consultant with experience in market opportunity assessments, competitive intelligence and asset valuation. Prior to joining Bluestar, he was a Senior Research Associate at Evercore ISI where he covered biotech companies focused on developing vaccines and products for rare and central nervous system diseases, with particular focus on renal diseases, mental health, and movement disorders. Matt holds a PhD in Molecular Biology from Princeton University and BS in Biological Sciences from Carnegie Mellon University.